Evidence map›Paper›PMID 28578535›Full record

ArticleEuropean journal of nutrition2018

Effect of increased water intake on plasma copeptin in healthy adults.

Guillaume Lemetais, Olle Melander, Mariacristina Vecchio, Jeanne H Bottin, Sofia Enhörning, Erica T Perrier

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in European journal of nutrition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02044679 (Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions), which is not on this map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02044679 nacompletednot on this map

Evaluation of Spot Urine as a Biomarker of Fluid Intake in Real Life Conditions

TypeinterventionalSponsorDanone Global Research & Innovation CenterRan2013 to 2014Enrolled82ConditionsHealthy AdultsArmsWater, No intervention
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 64 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Serum sodium, tonicity, and risk of dementia in cohort and healthcare populations.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Guillaume LemetaisHydration and Health Department, Danone Research, Route Départementale 128, 91767, Palaiseau, France.
Olle MelanderDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Mariacristina VecchioHydration and Health Department, Danone Research, Route Départementale 128, 91767, Palaiseau, France.
Jeanne H BottinHydration and Health Department, Danone Research, Route Départementale 128, 91767, Palaiseau, France.
Sofia EnhörningDepartment of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, Sweden.
Erica T PerrierHydration and Health Department, Danone Research, Route Départementale 128, 91767, Palaiseau, France. erica.perrier@danone.com.
Danone (France) · FRSkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeInter-individual variation in median plasma copeptin is associated with incident type 2 diabetes mellitus, progression of chronic kidney disease, and cardiovascular events. In this study, we examined whether 24-h urine osmolality was associated with plasma copeptin and whether increasing daily water intake could impact circulating plasma copeptin.

methodsThis trial was a prospective study conducted at a single investigating center. Eighty-two healthy adults (age 23.6 ± 2.9 years, BMI 22.2 ± 1.5 kg/m

resultsAt baseline, plasma copeptin was positively and significantly associated with 24-h urine osmolality (p = 0.002) and 24-h urine specific gravity (p = 0.003) but not with plasma osmolality (p = 0.18), 24-h urine creatinine (p = 0.09), and total fluid intake (p = 0.52). Over the 6-week follow-up, copeptin decreased significantly from 5.18 (3.3;7.4) to 3.90 (2.7;5.7) pmol/L (p = 0.012), while urine osmolality and urine specific gravity decreased from 591 ± 206 to 364 ± 117 mOsm/kg (p < 0.001) and from 1.016 ± 0.005 to 1.010 ± 0.004 (p < 0.001), respectively.

conclusionsAt baseline, circulating levels of copeptin were positively associated with 24-h urine concentration in healthy young subjects with various fluid intakes. Moreover, this study shows, for the first time, that increased water intake over 6 weeks results in an attenuation of circulating copeptin. CLINICAL TRIAL REGISTRATION NUMBER: NCT02044679.

Indexed as

DrinkingOsmolar ConcentrationUrinalysisAdultFemaleFranceGlycopeptidesHumansMaleProspective StudiescopeptinsGlycopeptidesCopeptinFluid intakeHydrationUrine osmolalityWater intake

Identifiers

PMID28578535
PMCPMC6060834
OpenAlexW2620961320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.